Bicocca Open Archive

Logo unimib boa
REDAELLI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.532
AS - Asia 3.849
EU - Europa 3.606
SA - Sud America 566
AF - Africa 102
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 9
Totale 15.676
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.360
SG - Singapore 1.402
CN - Cina 886
DE - Germania 751
IT - Italia 616
VN - Vietnam 516
RU - Federazione Russa 474
BR - Brasile 421
HK - Hong Kong 406
SE - Svezia 392
IE - Irlanda 379
UA - Ucraina 240
GB - Regno Unito 220
FR - Francia 169
IN - India 148
CA - Canada 120
FI - Finlandia 100
TR - Turchia 73
BD - Bangladesh 70
AR - Argentina 55
IQ - Iraq 51
PL - Polonia 51
KR - Corea 50
ES - Italia 44
ZA - Sudafrica 40
ID - Indonesia 37
NL - Olanda 36
BE - Belgio 34
JP - Giappone 33
PK - Pakistan 33
MX - Messico 29
AT - Austria 28
DK - Danimarca 27
VE - Venezuela 22
CO - Colombia 21
SA - Arabia Saudita 21
EC - Ecuador 17
UZ - Uzbekistan 16
PH - Filippine 15
AU - Australia 11
MA - Marocco 11
AZ - Azerbaigian 10
CL - Cile 10
JO - Giordania 10
KE - Kenya 10
EU - Europa 9
IR - Iran 9
EG - Egitto 8
ET - Etiopia 8
LT - Lituania 8
TN - Tunisia 8
BG - Bulgaria 7
NP - Nepal 7
PY - Paraguay 7
TH - Thailandia 7
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
JM - Giamaica 6
MY - Malesia 6
OM - Oman 6
PE - Perù 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
CH - Svizzera 5
GE - Georgia 4
IL - Israele 4
PS - Palestinian Territory 4
RO - Romania 4
TT - Trinidad e Tobago 4
KG - Kirghizistan 3
LB - Libano 3
MU - Mauritius 3
NO - Norvegia 3
PT - Portogallo 3
TW - Taiwan 3
AM - Armenia 2
AO - Angola 2
DZ - Algeria 2
NG - Nigeria 2
PA - Panama 2
RS - Serbia 2
SN - Senegal 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MG - Madagascar 1
MK - Macedonia 1
Totale 15.665
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.126
Singapore 830
Ashburn 794
Woodbridge 589
Fairfield 455
San Jose 425
Hong Kong 396
Frankfurt am Main 386
Chandler 372
Dublin 367
Houston 314
Wilmington 259
Milan 253
Dearborn 235
Jacksonville 227
Seattle 187
New York 179
Ho Chi Minh City 145
Beijing 143
Cambridge 137
Los Angeles 131
Dallas 117
Santa Clara 112
Hanoi 110
The Dalles 103
Princeton 101
Chicago 82
Shanghai 80
Göttingen 75
Nanjing 73
Hefei 64
Munich 63
Lauterbourg 54
Altamura 49
Seoul 43
São Paulo 43
Lawrence 42
Moscow 39
Lachine 37
Buffalo 35
Brussels 34
Helsinki 32
London 31
Warsaw 30
Da Nang 29
Nanchang 29
Tokyo 29
Council Bluffs 27
Boardman 26
Dong Ket 26
Jakarta 26
Fremont 25
Fürstenwalde 25
Shenyang 25
San Diego 24
Guangzhou 23
Turku 22
Johannesburg 21
Orem 21
Tianjin 21
Chennai 20
Vienna 20
Nuremberg 19
Toronto 19
Andover 18
Changsha 18
Haiphong 18
Montreal 18
Ottawa 18
Brooklyn 17
Salt Lake City 17
Falls Church 16
Rio de Janeiro 16
Baghdad 15
Denver 15
Jiaxing 15
Lodz 15
Pune 15
Düsseldorf 14
Hangzhou 14
Jinan 14
Manchester 14
Mumbai 14
Rome 14
Tashkent 14
Atlanta 13
Kocaeli 13
Lissone 13
Romola 13
Ankara 12
Buenos Aires 12
Hebei 12
Monza 12
San Francisco 12
Stockholm 12
Belo Horizonte 11
Boston 11
Istanbul 11
Norwalk 11
Pavia 11
Totale 10.384
Salva come PNG Salva come JPEG
Nome #
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways 598
Lorlatinib treatment elicits multiple on- and off-target mechanisms of resistance in ALK-driven cancer 519
Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study 446
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub 409
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia 405
Three novel patients derived BCR/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors 392
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 373
Idiopathic erythrocytosis: a germline disease? 365
Characterization of compound 584, an Abl kinase inhibitor with lasting effects 362
Synergistic activity of ALK and mTOR inhibitors for the treatment of NPM-ALK positive lymphoma 362
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia 356
In vitro and in vivo identification of ABCB1 as an efflux transporter of bosutinib 349
In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells 343
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia 339
ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells 326
Abstract 902: In vitro andin vivocharacterization of resistance to lorlatinib treatment in ALK mutated cancers 326
Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation 324
A New BCR-ABL1 Mutation (L248R) Is Highly Resistant to Imatinib, Bosutinib, Nilotinib and Dasatinib, but Can Be Inhibited by AP-24534 and DCC-2036 319
Inhibition of RET tyrosine kinase by SU5416 319
NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma 317
Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases 312
Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR/ABL mutants 311
CEQer: A Graphical Tool for Copy Number and Allelic Imbalance Detection from Whole-Exome Sequencing Data 306
Ponatinib is a potent inhibitor of wild-type and drug-resistant gatekeeper mutant RET kinase 301
Dual kinase targeting in leukemia 298
Recurrent SETBP1 Mutations in Atypical Chronic Myeloid Leukemia 296
BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients 290
Structural insights into the ATP binding pocket of the anaplastic lymphoma kinase by site-directed mutagenesis, inhibitor binding analysis, and homology modeling 287
Reply to P. Laneuville et al 284
Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients 278
In Vitro and in Vivo Characterization of Bosutinib as Substrate of the Pglycoprotein Efflux Transporter 278
ETNK1 is an early event and SETBP1 a late event in atypical Chronic Myeloid Leukemia 277
FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery 274
Identification of a Novel Splicing Mutation in Blast Crisis Transformation of Chronic Myeloid Leukemia Integrating Whole-exome and RNA-Seq data 268
Synergistic drug combinations prevent resistance in ALK+ anaplastic large cell lymphoma 262
Recurrent KIT D816V Mutation in Atypical Chronic Myeloid Leukemia 260
Expression, purification, and inhibition of human RET tyrosine kinase 258
Synergistic activity of the Src/Abl inhibitor bosutinib in combination with imatinib 254
Clonal evolution analysis identifies ETNK1 as an early event and SETBP1 as a late event in atypical Chronic Myeloid Leukemia 246
Determination of the Activity Profile of Bosutinib, Dasatinib and Nilotinib against 18 Imatinib Resistant Bcr/Abl Mutants 245
BCR and BCR/ABL Regulation during Myeloid Differentiation in Healthy Donors and in Chronic Phase/Blast Crisis CML Patients 241
BCR AND BCR-ABL REGULATION DURING MYELOID DIFFERENTIATION IN HEALTHY DONORS AND CHRONIC PHASE-BLAST CRISIS CML PATIENTS 228
Novel targeted therapeutics for MEN2 225
Bosutinib is a Substrate of the ABC Efflux Transporter P-Glycoprotein 220
NPM/ALK binds and phosphorylates the RNA/DNA binding protein PSF in anaplastic large cell lymphoma 218
Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBa mediated p53 nuclear exclusion 214
In vitro and in vivo activity of SKI-606, a novel Abl/Src inhibitor, against imatinib resistant BCR-ABL plus neoplastic 212
Synergistic Activity of ALK and mTOR Inhibitors for the Treatment of NPM-ALK Positive Lymphoma 212
Clinical and Molecular features of the patients with Idiopathic Erythrocytosis 209
Volatile Sedation for Acute Respiratory Distress Syndrome Patients on Venovenous Extracorporeal Membrane Oxygenation and Ultraprotective Ventilation 203
Resistance Profile of the BCR/ABL Inhibitor Bosutinib Using a High Throughput random Mutagenesis Assay 200
Synergistic drug combinations preventdrug resistance in anaplastic large cell lymphomapreclinical models 183
Paired Exome Sequencing Reveals Recurrent Germline Variants in Patients with Idiopathic Erythrocytosis 180
Rapid recognition of drug-resistance/sensitivity in leukemic cells by Fourier transform InfraRed microspectroscopy and unsupervised Hierarchical Cluster Analysis. 163
Totale 16.042
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.871
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.871
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021205 0 0 0 0 0 0 0 0 0 0 103 102
2021/2022755 53 77 83 47 51 70 38 34 37 81 64 120
2022/20231.491 169 461 145 151 93 197 18 81 84 23 33 36
2023/20241.066 28 34 43 60 139 299 217 38 54 23 15 116
2024/20252.250 141 224 153 129 203 72 151 89 194 378 196 320
2025/20265.234 693 283 487 623 747 285 846 224 466 565 15 0
Totale 16.042